Hypothesis: Myostatin is a mediator of cardiac cachexia
- 29 February 2008
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 124 (2) , 131-133
- https://doi.org/10.1016/j.ijcard.2007.07.058
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Myostatin Mutation Associated with Gross Muscle Hypertrophy in a ChildNew England Journal of Medicine, 2004
- Sarcopenia—consequences, mechanisms, and potential therapiesMechanisms of Ageing and Development, 2003
- Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failureEuropean Heart Journal, 1999
- Cardiac CachexiaChest, 1999
- Double muscling in cattle due to mutations in the myostatin geneProceedings of the National Academy of Sciences, 1997
- Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac CachexiaCirculation, 1997
- Skeletal Muscle Atrophy and Peak Oxygen Consumption in Heart FailureThe American Journal of Cardiology, 1997
- Regulation of skeletal muscle mass in mice by a new TGF-p superfamily memberNature, 1997
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990